Plenary Paper THROMBOSIS AND HEMOSTASIS Murine coagulation factor VIII is synthesized in endothelial cells
نویسندگان
چکیده
Plasma coagulation factor VIII (FVIII) is tightly associated with von Willebrand factor (VWF). Though it is well established that VWF is synthesized exclusively in endothelial cells andmegakaryocytes, the cellular source of FVIII has been debated for decades. The delayed rise of FVIII in von Willebrand disease patients infused with VWF demonstrates that VWF and FVIII do not require synthesis in the same cell for complex formation. Dozens of conflicting reports have implicated numerous cell and tissue types as the source of FVIII, though themajority of evidence points to either an endothelial and/or hepatocyte origin of FVIII synthesis. Multiple curative organ transplantation studies in hemophilia A patients and experimental dog models have shown that the liver contributes significantly to FVIII biosynthesis, though the failure of FVIII levels in hemophilia A liver transplant recipients to respond to desmopressin suggested FVIII localization to a different compartment than VWF. As early as 1971, Webster et al demonstrated extrahepatic FVIII synthesis by showing that FVIII synthesis was maintained after replacing the livers of normal dog recipients with hemophilic livers. Similarly, extrahepatic FVIII production was shown in humans after transplantation of a hemophilia A donor liver into a nonhemophilic recipient. Spleen and lung transplantation has also been shown to restore FVIII plasma levels in several animal models of hemophilia, and FVIII production also has been documented by human purified microvascular endothelial cells from lung in vitro. Immunoradiometric assays localized FVIII antigen to guinea pig liver, spleen, lung, kidney, and isolated hepatocytes and to human lymph nodes, lung, liver, and spleen, whereas microscopy studies suggested synthesis in human hepatocytes or human liver sinusoidal endothelial cells (LSECs). F8 messenger RNA (mRNA) transcripts have been detected in purified murine LSECs and hepatocytes at comparable levels, but not in Kupffer cells, and by others in human spleen, lymph nodes, kidney, and isolated hepatocytes, but not in white blood cells or cultured umbilical vein endothelial cells. F8 mRNA transcripts have also been shown to be synthesized in hemophilia A mouse livers by hepatocytes and LSECs that were derived from transplanted wild-type bone marrow progenitor cells. We took advantage of a genetically modifiedmouse model that is deficient for lectin,mannose-binding protein 1 (LMAM1), alsoknown as endoplasmic reticulum/Golgi intermediate compartment (ERGIC)53). LMAN1 is part of a ubiquitously expressed cargo receptor that cycles between the ERGIC in the early secretory pathway. LMAN1 is required for the efficient secretion of FVIII as well as coagulation FV to the plasma. Mutations in LMAN1 cause an autosomalrecessive bleeding disorder known as combined deficiency of coagulation FV and FVIII (F5F8D). Although FV and FVIII are synthesized at markedly different levels (human plasma FV ;7.0 mg/mL and FVIII ;200 ng/mL) and potentially in different tissues, loss of the LMAN1 cargo receptor in F5F8D leads to parallel
منابع مشابه
Endothelial cells synthesize FVIII Scientific section designation: THROMBOSIS AND HEMOSTASIS Title: Murine coagulation factor VIII is synthesized in endothelial cells
The primary cellular source of FVIII biosynthesis is controversial, with contradictory evidence supporting an endothelial or hepatocyte origin. LMAN1 is a cargo receptor in the early secretory pathway that is responsible for the efficient secretion of FV and FVIII to the plasma. Lman1 mutations result in combined deficiency of FV and FVIII, with levels of both factors reduced to ~10-15% of norm...
متن کاملEvaluation of Normal Range of Bleeding Scores in Healthy Iranian Adults using the International Society on Thrombosis and Hemostasis Bleeding Assessment Tool
Background: Bleeding assessment tools are key components in the evaluation of patients suspicious for bleeding disorders. The exact determination of the normal ranges of ISTH-BAT (International Society on Thrombosis and Hemostasis –Bleeding Assessment Tool) in the healthy population is a crucial step for determining who needs to be referred for further coagulation laboratory examinations. We ai...
متن کاملvon Willebrand factor: a marker of endothelial damage?
Von Willebrand factor (vWF), a large glycoprotein encoded by a gene on chromosome 12, is synthesized by vascular endothelial cells and circulates in human plasma at concentrations of 10 mg/mL.* In plasma, vWF forms a noncovalent complex with coagulation factor VIII, the protein encoded by a gene on the X chromosome that is deficient or defective in hemophilia A. This molecular complex is essent...
متن کاملHEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque
Thrombosis is the major mechanism underlying acute complications of atherosclerosis. Although thrombogenicity of atherosclerotic plaques has been ascribed to activation of the extrinsic pathway of blood coagulation, in the present study we investigated contribution of the intrinsic factor VIII (fVIII)–dependent pathway. We found that in vitro exposure of human macrophages and smooth muscle cell...
متن کاملRituximab for Treatment of Hemophilia A with High-Responder Inhibitors
Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...
متن کامل